skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines zoledronic acid anhydrousQuestion & answer

zoledronic acid anhydrous · Medicine question

Can it lower calcium caused by cancer?

iatroX medicinesPublished 22 August 2026Reviewed 22 August 2026

The answer

Answer

Yes. The selected product is licensed to treat tumour-induced hypercalcaemia in adults by reducing calcium release from bone.

Sources for this answer

Zoledronic acid 4 mg/5 ml concentrate for solution for infusionemc · SmPC Current selected SmPC · Version 4

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

zoledronic acid anhydrous

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the zoledronic acid anhydrous guide

More questions about zoledronic acid anhydrous

Why is it used when cancer has spread to bone?Is it an infusion or a tablet?Why are blood tests needed?Why must I tell my dentist?Can it affect the kidneys?Can it be used during pregnancy or breastfeeding?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX